Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy. (2017)

First Author: Bedard M

Attributed to: Tumour Immunology funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2017.01829

PubMed Identifier: 29326711

Publication URI: http://europepmc.org/abstract/MED/29326711

Type: Journal Article/Review

Volume: 8

Parent Publication: Frontiers in immunology

ISSN: 1664-3224